Global Multiplex Biomarker Imaging Market (2018-2023)

The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According to Netscribes, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018-2023 period, generating a revenue of USD 523.59 Mn by 2023.

The global multiplex biomarker imaging market can be segmented based on:

o Techniques - immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
o Components - instruments, reagents and kits, and software
o Applications - oncology studies, drug safety, genetic characterization, and others (neurodegeneration and protein research)
o End users - research institutes, translational labs, and pharma and biopharma companies

Technique segment insights:

IHC held the largest market share (around 47%) in this segment in 2017. It is widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis-à-vis traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing to the growth of TMA. The market for TMA is projected to expand at a CAGR of 14.3% during the 2018-2023 period.
Component segment insights:

The instruments section held the largest market share (67%) in 2017, followed by reagents and kits. However, software is predicted to record the fastest expansion (CAGR of 15.0%) during the forecast period (2018-2023), with more automated software packages being made available to researchers. These software modules assist in the research of various diseases and improve the workflow of quantitative analysis.

Application segment insights:

Multiplex biomarker imaging products are used mostly in oncology studies. This will be followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018-2023.

End user segment insights:

Currently, multiplex biomarker imaging products can only be used for research purposes. Pharma and biopharma companies dominated the market's end user segment in 2017 with a share of 39%. Meanwhile, translational laboratories are projected to grow at a significant rate during the forecast period.

Regional insights:

The global multiplex biomarker imaging market can be segmented based on regions into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global multiplex biomarker imaging market with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018-2023. Across North America and Europe, companies that have software and service agreements for several years are directly selling imaging products to biopharmaceutical companies, laboratories, and academic institutions.

Companies covered:

o Thermo Fisher Scientific, Inc.
o Perkin Elmer, Inc.
o Abcam Plc.
o Bio-Rad Laboratories Inc.
o US Biomax, Inc.
o Merck KGaA
o Ventana Medical Systems, Inc.
o MicroConstants, Inc.
o Leica Biosystems Nussloch GmbH
o ToposNomos Ltd.
o Illumina, Inc.

Customizations available
With the given market data, Netscribes offers customizations according to specific needs. Write to us at [email protected], or connect with us here.
Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2: Global multiplex biomarker imaging market - overview

2.1. Global market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), geography-wise market revenue (USD Mn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
2.8. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
2.9. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
2.10. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 3: North America multiplex biomarker imaging market

3.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
3.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
3.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 4: Europe multiplex biomarker imaging market

4.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
4.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
4.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
4.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
4.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 5: Asia-Pacific multiplex biomarker imaging market

5.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
5.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
5.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
5.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
5.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 6: Latin America multiplex biomarker imaging market

6.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
6.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
6.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
6.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
6.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 7: The Middle East and Africa multiplex biomarker imaging market

7.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
7.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
7.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
7.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
7.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 8: Competitive landscape

8.1. Thermo Fisher Scientific, Inc.
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Growth strategies
8.1.d. Initiatives
8.1.e. Geographical presence
8.1.f. Key numbers
8.2. Perkin Elmer, Inc.
8.2.a. Company snapshot
8.2.b. Product offerings
8.2.c. Growth strategies
8.2.d. Initiatives
8.2.e. Geographical presence
8.2.f. Key numbers
8.3. Abcam Plc.
8.3.a. Company snapshot
8.3.b. Product offerings
8.3.c. Growth strategies
8.3.d. Initiatives
8.3.e. Geographical presence
8.3.f. Key numbers
8.4. Bio-Rad Laboratories Inc.
8.4.a. Company snapshot
8.4.b. Product offerings
8.4.c. Growth strategies
8.4.d. Initiatives
8.4.e. Geographical presence
8.4.f. Key numbers
8.5. U.S. Biomax, Inc.
8.5.a. Company snapshot
8.5.b. Product offerings
8.5.c. Growth strategies
8.5.d. Initiatives
8.5.e. Geographical presence
8.5.f. Key numbers
8.6. Merck KGaA
8.6.a. Company snapshot
8.6.b. Product offerings
8.6.c. Growth strategies
8.6.d. Initiatives
8.6.e. Geographical presence
8.6.f. Key numbers
8.7. Ventana Medical Systems, Inc.
8.7.a. Company snapshot
8.7.b. Product offerings
8.7.c. Growth strategies
8.7.d. Initiatives
8.7.e. Geographical presence
8.7.f. Key numbers
8.8. MicroConstants, Inc.
8.8.a. Company snapshot
8.8.b. Product offerings
8.8.c. Growth strategies
8.8.d. Initiatives
8.8.e. Geographical presence
8.8.f. Key numbers
8.9. Leica Biosystems Nussloch GmbH
8.9.a. Company snapshot
8.9.b. Product offerings
8.9.c. Growth strategies
8.9.d. Initiatives
8.9.e. Geographical presence
8.9.f. Key numbers
8.10. ToposNomos Ltd.
8.10.a. Company snapshot
8.10.b. Product offerings
8.10.c. Growth strategies
8.10.d. Initiatives
8.10.e. Geographical presence
8.10.f. Key numbers
8.11. Illumina, Inc.
8.11.a. Company snapshot
8.11.b. Product offerings
8.11.c. Growth strategies
8.11.d. Initiatives
8.11.e. Geographical presence
8.11.f. Key numbers

Chapter 9: Conclusion
9.1. Future Outlook

Appendix
o List of tables
o Research methodology
o Assumptions
o About Netscribes, Inc.

Global Multiplex Assay Market Research Report 2019-2023

Published Date : Aug 2019

In the biological sciences, a multiplex assay is a type of immunoassay that uses magnetic beads to simultaneously measure multiple analytes in a single experiment. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Multip...

Global Structural Heart Imaging Market Research Report 2019-2023

Published Date : Jul 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Structural Heart Imaging Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major...

Global Nuclear Medicine Molecular Imaging Technology Market Research Report 2019-2023

Published Date : Jul 2019

Nuclear Medicine and Molecular Imaging Technology is a patient-oriented program that combines chemistry, physics, mathematics, computer technology, and medicine using radioactivity to construct images of organs and study physiological processes for diagnostic, therapeutic and research purposes....

Global Molecular Imaging (PET-CT) Market Research Report 2019-2023

Published Date : Jul 2019

Molecular imaging originated from the field of radiopharmacology due to the need to better understand fundamental molecular pathways inside organisms in a noninvasive manner. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this mar...

Global Molecular Biomarker Market Research Report 2019-2023

Published Date : Jul 2019

A Molecular Biomarker is a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism. The consumption of Mo...

Global Infrared Imaging Market Research Report 2019-2023

Published Date : Jul 2019

The IR imaging market is poised for high growth on account of growing adoption in previously untapped applications. IR cameras were initially developed for military applications, which accounted for a majority of the global market revenue. For several years, the technology was limited to military & ...

Global Low-Light Imaging Market Research Report 2019-2023

Published Date : Jul 2019

Photonis is market leader in photon imaging and has successfully incorporated image sensors intoLow Light Imaging Devices. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Low-Light Imaging Report by Material, Applicati...

Global Hyperspectral Imaging Market Research Report 2019-2023

Published Date : Jul 2019

Hyperspectral imaging, like other spectral imaging, collects and processes information from across the electromagnetic spectrum. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Hyperspectral Imaging Report by Material,...

Global Hyperspectral Imaging Cameras Market Research Report 2019-2023

Published Date : Jul 2019

Hyperspectral imaging cameras can be used in any of our systems, including the laboratory benchtop system, tripod-based outdoor field system, and airborne remote sensing system. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this ...

Global Polarized Imaging Camera Market Research Report 2019-2023

Published Date : Jul 2019

Sony expands its sensor technology leadership by developing their first polarized sensor with their Polarsens technology. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Polarized Imaging Camera Report by Material, App...

 

Select License :

  • Single User : $2950

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.